authors
- Antonia, S
- Gettinger, S
- Borghaei, H
- Goldman, JW
- Brahmer, J
- Ready, N
- Gerber, D
- Chow, L
- Juergens, Rosalyn
- Laurie, S
- Shepherd, F
- Li, X
- Li, A
- Geese, W
- Hellmann, M
P1.01-02 Long-Term Outcomes with First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 3-Year Follow-Up from CheckMate 012
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 2018
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Thoracic Oncology Journal